Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.49 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | LRRK2 | Q5S007 | 9/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21799424 | 0.91 | SGMS2 (0.47) | SGMS2CYP11B1CYP11B2CYP19A1LRRK2 | |
| SCHEMBL21799397 | 0.87 | NPC1 (0.54) | SGMS2CYP11B1CYP11B2LRRK2KMT2A | |
| SCHEMBL21799368 | 0.81 | NPC1 (0.39) | KMT2AALDH1A1HTTMEN1 | |
| SCHEMBL4718330 | 0.76 | PTGER1 (0.49) | KMT2ALMNAMEN1 | |
| SCHEMBL10290923 | 0.76 | KMT2A (0.48) | KMT2ATDP1ALDH1A1HPGDNPSR1 | |
| SCHEMBL28308385 | 0.75 | ALDH1A1 (0.51) | KMT2AALDH1A1HTTHPGD | |
| SCHEMBL168289 | 0.75 | DGAT1 (0.45) | CYP11B1CYP11B2CYP19A1KMT2ALMNA | |
| Hydrochloric Acid SCHEMBL518722 | 0.75 | KMT2A (0.47) | KMT2ATDP1ALDH1A1HPGDNPSR1 | |
| SCHEMBL28308383 | 0.74 | CYP1A2 (0.48) | CYP11B1CYP11B2KMT2ALMNAALDH1A1 | |
| SCHEMBL20239588 | 0.72 | NPC1 (0.51) | KMT2AALDH1A1NPSR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11993578-B2 | Pyrazole-3-carboxylic acid amide derivative and pest control agent | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-05-28 | — | — | US | disclosed |
| CN-110612295-B | Pyrazole-3-carboxylic acid amide derivative and pest control agent | 组合化学工业株式会社 | 2023-07-14 | — | — | CN | disclosed |
| EP-3623365-B1 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2023-01-04 | — | — | EP | disclosed |
| US-20200199096-A1 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2020-06-25 | — | — | US | disclosed |
| EP-3623365-A1 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | Kumiai Chemical Industry Co., Ltd. (JP) | 2020-03-18 | — | — | EP | disclosed |
| CN-110612295-A | Pyrazole-3-carboxylic acid amide derivative and pest control agent | 组合化学工业株式会社 | 2019-12-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200199096-A1 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | H1-3, HDAC3, H1-0 | SGMS2 2580/4885CYP11B1 1719/4885CYP11B2 1806/4885 |
| US-11993578-B2 | Pyrazole-3-carboxylic acid amide derivative and pest control agent | H1-3, HDAC3, H1-0 | SGMS2 2580/4885CYP11B1 1719/4885CYP11B2 1806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.